![IJMS | Free Full-Text | Epidemiology, Pathogenesis, and Diagnostic Strategy of Diabetic Liver Disease in Japan IJMS | Free Full-Text | Epidemiology, Pathogenesis, and Diagnostic Strategy of Diabetic Liver Disease in Japan](https://www.mdpi.com/ijms/ijms-21-04337/article_deploy/html/images/ijms-21-04337-g001.png)
IJMS | Free Full-Text | Epidemiology, Pathogenesis, and Diagnostic Strategy of Diabetic Liver Disease in Japan
![Recommendations for the detection, diagnosis and follow-up of patients with non-alcoholic fatty liver disease in primary and hospital care - ScienceDirect Recommendations for the detection, diagnosis and follow-up of patients with non-alcoholic fatty liver disease in primary and hospital care - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2387020619303110-gr1.jpg)
Recommendations for the detection, diagnosis and follow-up of patients with non-alcoholic fatty liver disease in primary and hospital care - ScienceDirect
![The FibroScan-aspartate aminotransferase score can stratify the disease severity in a Japanese cohort with fatty liver diseases | Scientific Reports The FibroScan-aspartate aminotransferase score can stratify the disease severity in a Japanese cohort with fatty liver diseases | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-021-93435-x/MediaObjects/41598_2021_93435_Fig1_HTML.png)
The FibroScan-aspartate aminotransferase score can stratify the disease severity in a Japanese cohort with fatty liver diseases | Scientific Reports
![How can we predict steatosis using biochemical markers (SteatoTest and Fatty liver index) | Semantic Scholar How can we predict steatosis using biochemical markers (SteatoTest and Fatty liver index) | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/ef306ace42db03995f659a9d2bbe66b9e3c84cc7/3-Table1-1.png)
How can we predict steatosis using biochemical markers (SteatoTest and Fatty liver index) | Semantic Scholar
![HCV-Trials.com : A regularly updated website with all most recent clinical trials data in HCV infection HCV-Trials.com : A regularly updated website with all most recent clinical trials data in HCV infection](http://www.hcv-trials.com/nash/NAFLD-NASH/big/Diapositive6.jpg)
HCV-Trials.com : A regularly updated website with all most recent clinical trials data in HCV infection
Association Between 10-Year Fracture Probability and Nonalcoholic Fatty Liver Disease With or Without Sarcopenia in Korean Men:
![Diagnostics | Free Full-Text | Non-Alcoholic Fatty Liver Disease Defined by Fatty Liver Index and Incidence of Heart Failure in the Korean Population: A Nationwide Cohort Study Diagnostics | Free Full-Text | Non-Alcoholic Fatty Liver Disease Defined by Fatty Liver Index and Incidence of Heart Failure in the Korean Population: A Nationwide Cohort Study](https://www.mdpi.com/diagnostics/diagnostics-12-00663/article_deploy/html/images/diagnostics-12-00663-g001.png)
Diagnostics | Free Full-Text | Non-Alcoholic Fatty Liver Disease Defined by Fatty Liver Index and Incidence of Heart Failure in the Korean Population: A Nationwide Cohort Study
![Receiver operator characteristic curve (ROC) for fatty liver index,... | Download Scientific Diagram Receiver operator characteristic curve (ROC) for fatty liver index,... | Download Scientific Diagram](https://www.researchgate.net/publication/277409909/figure/fig1/AS:444239826952192@1482926436364/Receiver-operator-characteristic-curve-ROC-for-fatty-liver-index-hepatic-steatosis.png)
Receiver operator characteristic curve (ROC) for fatty liver index,... | Download Scientific Diagram
![Serum biomarkers and cut-off values for prediction of hepatic steatosis... | Download Scientific Diagram Serum biomarkers and cut-off values for prediction of hepatic steatosis... | Download Scientific Diagram](https://www.researchgate.net/publication/344284944/figure/tbl2/AS:936732681859072@1600345883123/Serum-biomarkers-and-cut-off-values-for-prediction-of-hepatic-steatosis-and-significant.png)
Serum biomarkers and cut-off values for prediction of hepatic steatosis... | Download Scientific Diagram
![Ursodeoxycholic acid as a means of preventing atherosclerosis, steatosis and liver fibrosis in patients with nonalcoholic fatty liver disease Ursodeoxycholic acid as a means of preventing atherosclerosis, steatosis and liver fibrosis in patients with nonalcoholic fatty liver disease](https://f6publishing.blob.core.windows.net/bc908986-97bf-4103-ac40-6d1ff9075951/WJG-27-959-g001.png)
Ursodeoxycholic acid as a means of preventing atherosclerosis, steatosis and liver fibrosis in patients with nonalcoholic fatty liver disease
![Frontiers | Nomogram for Quantitatively Estimating the Risk of Fibrosis Progression in Type 2 Diabetic Patients With Nonalcoholic Fatty Liver Disease: A Pilot Study Frontiers | Nomogram for Quantitatively Estimating the Risk of Fibrosis Progression in Type 2 Diabetic Patients With Nonalcoholic Fatty Liver Disease: A Pilot Study](https://www.frontiersin.org/files/Articles/917304/fendo-13-917304-HTML/image_m/fendo-13-917304-g001.jpg)
Frontiers | Nomogram for Quantitatively Estimating the Risk of Fibrosis Progression in Type 2 Diabetic Patients With Nonalcoholic Fatty Liver Disease: A Pilot Study
![Table 1 from AST to Platelet Ratio Index and fibrosis 4 calculator scores for non-invasive assessment of hepatic fibrosis in patients with non-alcoholic fatty liver disease. | Semantic Scholar Table 1 from AST to Platelet Ratio Index and fibrosis 4 calculator scores for non-invasive assessment of hepatic fibrosis in patients with non-alcoholic fatty liver disease. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/c09d483d7e3b5859fb9184338691134c5092a766/22-Table1-1.png)
Table 1 from AST to Platelet Ratio Index and fibrosis 4 calculator scores for non-invasive assessment of hepatic fibrosis in patients with non-alcoholic fatty liver disease. | Semantic Scholar
![NAFLD and thyroid function: pathophysiological and therapeutic considerations: Trends in Endocrinology & Metabolism NAFLD and thyroid function: pathophysiological and therapeutic considerations: Trends in Endocrinology & Metabolism](https://www.cell.com/cms/attachment/7f2b3b3c-5027-441a-a0df-e95a0f9c5846/gr1_lrg.jpg)
NAFLD and thyroid function: pathophysiological and therapeutic considerations: Trends in Endocrinology & Metabolism
![PDF] Role of Fatty Liver Index and Metabolic Factors in the Prediction of Nonalcoholic Fatty Liver Disease in a Lean Population Receiving Health Checkup | Semantic Scholar PDF] Role of Fatty Liver Index and Metabolic Factors in the Prediction of Nonalcoholic Fatty Liver Disease in a Lean Population Receiving Health Checkup | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/358ceae6bb31ee04c9e43d4f8819afdcb30b9911/5-Table4-1.png)
PDF] Role of Fatty Liver Index and Metabolic Factors in the Prediction of Nonalcoholic Fatty Liver Disease in a Lean Population Receiving Health Checkup | Semantic Scholar
![Health-care provision and policy for non-alcoholic fatty liver disease in sub-Saharan Africa - The Lancet Gastroenterology & Hepatology Health-care provision and policy for non-alcoholic fatty liver disease in sub-Saharan Africa - The Lancet Gastroenterology & Hepatology](https://www.thelancet.com/cms/asset/87d9133c-bb15-4be6-978a-e81c4d494678/gr1.jpg)
Health-care provision and policy for non-alcoholic fatty liver disease in sub-Saharan Africa - The Lancet Gastroenterology & Hepatology
![PDF) Fatty liver index and hepatic steatosis index predict non-alcoholic fatty liver disease in type 1 diabetes: hepatic steatosis indices for NAFLD prediction in type 1 diabetes PDF) Fatty liver index and hepatic steatosis index predict non-alcoholic fatty liver disease in type 1 diabetes: hepatic steatosis indices for NAFLD prediction in type 1 diabetes](https://www.researchgate.net/profile/Jelizaveta-Sokolovska/publication/316651256/figure/tbl1/AS:613447830102063@1523268768764/Correlation-R-of-factors-associated-with-liver-intrahepatic-fat-content-fatty-liver_Q320.jpg)
PDF) Fatty liver index and hepatic steatosis index predict non-alcoholic fatty liver disease in type 1 diabetes: hepatic steatosis indices for NAFLD prediction in type 1 diabetes
![Lipid accumulation product independently correlate with hepatic steatosis quantified by controlled attenuation parameter in women with polycystic ovary syndrome in: Endocrine Connections Volume 9 Issue 2 (2020) Lipid accumulation product independently correlate with hepatic steatosis quantified by controlled attenuation parameter in women with polycystic ovary syndrome in: Endocrine Connections Volume 9 Issue 2 (2020)](https://ec.bioscientifica.com/view/journals/ec/9/2/images/EC-19-0559equ1.jpeg)
Lipid accumulation product independently correlate with hepatic steatosis quantified by controlled attenuation parameter in women with polycystic ovary syndrome in: Endocrine Connections Volume 9 Issue 2 (2020)
![Ursodeoxycholic acid as a means of preventing atherosclerosis, steatosis and liver fibrosis in patients with nonalcoholic fatty liver disease Ursodeoxycholic acid as a means of preventing atherosclerosis, steatosis and liver fibrosis in patients with nonalcoholic fatty liver disease](https://f6publishing.blob.core.windows.net/bc908986-97bf-4103-ac40-6d1ff9075951/WJG-27-959-g002.png)